NCT Number: NCT00006061
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
OBJECTIVES: I. Determine whether plasma choline and breast milk choline levels are low at fasting in a patient with methionine adenosyltransferase deficiency, and if the choline levels are low, determine whether choline levels respond to dietary supplementation with phosphatidylcholine.
II. Determine whether this patient has a fatty liver by magnetic resonance spectroscopy.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–20 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
PROTOCOL OUTLINE:
Blood is drawn for liver function tests and measurement of plasma choline levels and breast milk samples are taken for measurement of breast milk choline levels at fasting and at 1 hour after breakfast on day 1. The patient then undergoes magnetic resonance spectroscopy of the liver to assess liver density and choline compound mass. The patient then receives oral phosphatidylcholine supplement, and plasma and breast milk samples are taken at 3 and 6 hours after the dose. Oral phosphatidylcholine supplements continue for 30 days. The above studies are repeated on day 31.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
- Patient with methionine adenosyltransferase deficiency who is nursing
Treatment and study plan
Sponsors and collaborators
Lead sponsor
National Center for Research Resources (NCRR)
Nih
Collaborators
- UNC Lineberger Comprehensive Cancer Center
Registry information
Important dates
- Study start
- 2000
- Study completion
- 2000
- First posted
- Jul 6, 2000
- Registry last updated
- Jun 24, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Genetic Etiology in Patients With Cerebral Palsy
NCT05123768
Aromatic amino acid decarboxylase deficiency, Ataxia
Ljubljana, Slovenia
View Trial DetailsNorth Carolina Newborn Exome Sequencing for Universal Screening
NCT02826694
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ear Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsMeasure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
NCT00362180
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Amsterdam, Netherlands
View Trial DetailsOpen Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
NCT00477594
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chicago, Illinois, United States
View Trial Details